Latest / Bloomberg Law / Bayer’s $2 Billion Roundup Verdict Raises the Stakes
Transcript
- 0:03Speaker 1: Welcome to the Bloomberg Law Podcast. I'm June Grosso. Every
- 0:07Speaker 1: day we bring you insight and analysis into the most
- 0:09Speaker 1: important legal news of the day. You can find more
- 0:12Speaker 1: episodes of the Bloomberg Law Podcast on Apple podcast, SoundCloud
- 0:16Speaker 1: and on Bloomberg dot com slash podcast. It's the largest
- 0:20Speaker 1: jury award in the US so far this year, and
- 0:22Speaker 1: the third consecutive legal defeat for Buyer. A jury has
- 0:26Speaker 1: awarded more than two billion dollars to a California couple
- 0:29Speaker 1: who claimed they got cancer as a result of using
- 0:32Speaker 1: its round up weed killer for about three decades. Will
- 0:35Speaker 1: Buyer reevaluate its legal strategy of fighting every case and
- 0:39Speaker 1: appealing every verdict? Joining me is Robert Hocket, a professor
- 0:43Speaker 1: at Cornell Law School. So Bob Buyer is three and
- 0:46Speaker 1: oh in jury trials. It could be liable for hundreds
- 0:50Speaker 1: of billions of dollars in damages if these jury verdicts
- 0:53Speaker 1: are repeated. How should it be weighing the importance of
- 0:57Speaker 1: this third loss? Hi? Do I think they should probably
- 1:02Speaker 1: view this as a kind of a perverse version of
- 1:04Speaker 1: three times as a charm, right, or third times a charm?
- 1:07Speaker 1: In other words, they should pack it in now this
- 1:09Speaker 1: is sort of you know, three strikes and you're out.
- 1:11Speaker 1: They really ought to start looking seriously into a settlement, right.
- 1:15Speaker 1: You and I have talked about this a couple of
- 1:16Speaker 1: times before they keep losing. It's not at all surprising
- 1:19Speaker 1: that they're losing. The merits of the plaintiffs cases look
- 1:22Speaker 1: very very strong, and the basis that buyer keeps giving
- 1:25Speaker 1: for continuing to hold out is very flimsy looking. So
- 1:29Speaker 1: it's beginning to look to me like the height of
- 1:30Speaker 1: foolishness or foolhardiness for buyer to continue to sort of
- 1:34Speaker 1: contest these particular cases. They really ought to be looking
- 1:37Speaker 1: in the settlement now. When the company's lawyer asked a
- 1:40Speaker 1: juror after the verdict what the jury wanted to hear
- 1:43Speaker 1: from Buyer, the juror said he wanted proof the chemical
- 1:46Speaker 1: was safe. Quote, I wanted you to get up and
- 1:49Speaker 1: drink it now, buyer want. Buyer wanted to tell the
- 1:52Speaker 1: jury that the e p A concluded last month that
- 1:56Speaker 1: roundups active ingredient is non carson a j and it
- 2:00Speaker 1: imposes no risk to the public health. Will that lead
- 2:04Speaker 1: to a reversal on appeal? Not? There's not a chance
- 2:08Speaker 1: in heydays of that, I don't think. I mean, the
- 2:11Speaker 1: thing to keep in mind here is that the you know,
- 2:13Speaker 1: the controversy around round up has been going on for
- 2:15Speaker 1: literally decades now, and there's just rutles and rutles of evidence,
- 2:19Speaker 1: you know, to the effect that it does have a
- 2:22Speaker 1: tendency to elevate your likelihood of acquiring some form of cancer. Right,
- 2:26Speaker 1: And so one last minute addition to the evidentiary pool,
- 2:31Speaker 1: in a pool that has hundreds of documents already, and
- 2:35Speaker 1: from the Trump e p A of all things, the
- 2:38Speaker 1: thought that that itself would suffice to overturn all of
- 2:42Speaker 1: this and change the course of history just on a dime.
- 2:45Speaker 1: I think it's just again the height of rule heartiness.
- 2:48Speaker 1: The verdict will likely be reduced the punitives, it's practically
- 2:52Speaker 1: all punitives, two billion im punitives compared to the rest. Now.
- 2:58Speaker 1: It also parts of that they're going to be appeals
- 3:01Speaker 1: in in the three cases. If buyer should win those appeals,
- 3:06Speaker 1: should that factor into its decision to settle or not
- 3:11Speaker 1: um it would it would definitely make sense for it
- 3:14Speaker 1: to factory in where that to happen, but it wouldn't
- 3:16Speaker 1: be dispositive. And it's also I think highly unlikely that
- 3:19Speaker 1: it's going to happen. The only the only ground on
- 3:22Speaker 1: which are the only sort of element of the most
- 3:24Speaker 1: recent decision that could be changed would be that the
- 3:27Speaker 1: punitive damages might be lowered by a bit. Right, there's
- 3:29Speaker 1: a kind of a rough benchmarker guideline at the courts
- 3:32Speaker 1: apply sometimes now to the effect that the punitives are
- 3:35Speaker 1: about ten times the compensatory um. That would mean in
- 3:39Speaker 1: this particular case, maybe cutting it back from two billion
- 3:42Speaker 1: to one billion, that would still be hardly chump change. Uh.
- 3:46Speaker 1: And again, given the apparent egregiousness with which Buyer seems
- 3:51Speaker 1: to have tried to conceal the controversy around round of
- 3:54Speaker 1: itself from people, the punitives are really prompted by that
- 3:57Speaker 1: right by a determination that Buyer is not that good
- 4:00Speaker 1: faith that has been acting a bit like the tobacco
- 4:02Speaker 1: companies did, as revealed in the suits around tobacco litigation. Right,
- 4:08Speaker 1: So you know, they might get a little bit of
- 4:11Speaker 1: a cut in that punitive damage award, but I really
- 4:14Speaker 1: doubt that they're going to see overturnings of the verdicts
- 4:17Speaker 1: on the marriage or you know, elimination or cutting of
- 4:20Speaker 1: the other commensatory damages in these cases. How do you
- 4:23Speaker 1: get plaintiffs to settle when they see that people in
- 4:28Speaker 1: cases are winning billions and that might be reduced to
- 4:32Speaker 1: a hundred million, but it's still a huge verdict. Why
- 4:36Speaker 1: would they want to settle? Well, that's that's a really
- 4:39Speaker 1: important question, Jim, that I don't think has actually been
- 4:41Speaker 1: posed enough out there in the press. But with every
- 4:44Speaker 1: loss that buyer suffers, the more recount, the more sort
- 4:47Speaker 1: of reluctant future plaintiffs are going to be to settle.
- 4:51Speaker 1: And that means that in a sense, time is kind
- 4:53Speaker 1: of running out on the opportunity to settle, which if
- 4:57Speaker 1: buyer indeed takes advantage of that opportunity, could save it
- 5:01Speaker 1: literally millions, if not billions of dollars. So this is
- 5:03Speaker 1: another reason for them really to start getting serious about
- 5:06Speaker 1: possibly settling. Here. As for why plaintiffs might nevertheless settle,
- 5:11Speaker 1: notwithstanding the string of victories that they've racked up so far,
- 5:14Speaker 1: it just sort of depends on how quickly you need
- 5:16Speaker 1: the money, so to speak, or how quickly you'd want
- 5:18Speaker 1: the money. Right, it does take a while to litigate
- 5:20Speaker 1: to get those bigger UH damages awards UH and so
- 5:23Speaker 1: you can imagine plenty of plaintiffs being willing to take
- 5:26Speaker 1: a settlement now rather than having to litigate, even though
- 5:29Speaker 1: they know that their prospects of winning are higher and
- 5:31Speaker 1: higher with each new suit that buyer loses in the
- 5:34Speaker 1: years of appeals. Now is reaching a settlement also complicated
- 5:39Speaker 1: by the fact that this product is continuing to be sold,
- 5:44Speaker 1: So as days go on, buyer maybe adding new plaintiffs
- 5:48Speaker 1: to this pool of plaintiffs. Yeah, I mean, I think
- 5:51Speaker 1: that's that's that's definitely true, right, I mean, they're more
- 5:54Speaker 1: potential plaintiffs with each passing month that the product is sold.
- 5:57Speaker 1: I'm sure that buyer is banking on the proposit that maybe,
- 6:00Speaker 1: somehow or another, after all of these years, the product
- 6:03Speaker 1: will nevertheless be quote unquote proven to be safe. But
- 6:07Speaker 1: that's again, that's that would be quite a hail, Mary Hope.
- 6:10Speaker 1: It seems to me and the juror whom you quoted before,
- 6:13Speaker 1: I think it is just the you know, the kind
- 6:14Speaker 1: of the poster child for the attitude that people have now,
- 6:17Speaker 1: which is that after all these years, the presumption is
- 6:19Speaker 1: definitely to the effect that this is a dangerous product.
- 6:23Speaker 1: And what that means is that the burden of proof
- 6:24Speaker 1: is now on buy or to show that it's not unsafe,
- 6:28Speaker 1: whereas you know, way back when the burden would have
- 6:31Speaker 1: been on the plaintiffs to show that it is unsafe.
- 6:33Speaker 1: But again, the fact that the presumption is shifted in
- 6:35Speaker 1: this way, I think makes it even more surprising that
- 6:38Speaker 1: buyer is not looking into um settling. So um, this
- 6:44Speaker 1: verdict is coming about two weeks after shareholders expressed their
- 6:48Speaker 1: disapproval of the way the CEO has handled this month
- 6:53Speaker 1: Santo acquisition. Does that put pressure on them to put
- 6:57Speaker 1: aside more money for litigation loss or to settle? I
- 7:02Speaker 1: think it puts a great deal of pressure on them
- 7:05Speaker 1: actually to settle, uh, and if anything, maybe to set
- 7:08Speaker 1: aside money for possible shareholder suits that might ultimately be
- 7:11Speaker 1: brought against the board and the officers at the firm. Right,
- 7:15Speaker 1: because at this point it really is beginning to look reckless. Um,
- 7:19Speaker 1: you know what what the management of buyer is doing
- 7:22Speaker 1: in continuing to refuse to settle and continuing to sort
- 7:25Speaker 1: of hemorrhage money in the form of damages that are
- 7:29Speaker 1: awarded to various plaintiffs. At some point, the duty to
- 7:32Speaker 1: the shareholders begins to be um. You know, kind of
- 7:35Speaker 1: come into question here whether the the whether the board
- 7:39Speaker 1: UH is actually conforming to or acting in importance with
- 7:43Speaker 1: its duty to shareholders begins to come into questions. So
- 7:46Speaker 1: if they're going to set aside money, it seems to
- 7:48Speaker 1: me that they might want to set it aside a
- 7:50Speaker 1: for an actual settlement and be maybe for shareholder suits
- 7:53Speaker 1: down the pike. All right, Thanks so much, Bob. As always,
- 7:56Speaker 1: that's Robert Hocket. He's a professor at Cornell Law School.
- 8:00Speaker 1: Now a note, analyst at Bloomberg Intelligence have raised their
- 8:04Speaker 1: estimate for a settlement value for these lawsuits to as
- 8:07Speaker 1: much as ten billion dollars. That's up from a peak
- 8:11Speaker 1: of two billion dollars. Thanks for listening to the Bloomberg
- 8:14Speaker 1: Law Podcast. You can subscribe and listen to the show
- 8:17Speaker 1: on Apple Podcasts, SoundCloud, and on Bloomberg dot com slash podcast.
- 8:22Speaker 1: I'm June Brasso. This is Bloomberg